In conclusion, our findings provide a new perspective on the pathogenesis of COPD combined with AF from the viewpoint of the inflammatory immune response and suggest a biomarker CDK8 that could potentially be a therapeutic target. This evidence concerns the gene CDK8 and atrial fibrillation.